H Kollaritsch
Overview
Explore the profile of H Kollaritsch including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
73
Citations
599
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Kollaritsch H, Kundi M, Giaquinto C, Paulke-Korinek M
Clin Microbiol Infect
. 2015 Feb;
21(8):735-43.
PMID: 25680314
By January 2015, rotavirus vaccination had been implemented in national vaccination programmes in 75 countries worldwide. Two live oral rotavirus vaccines are internationally available: human, monovalent vaccine and human-bovine pentavalent...
2.
Klobassa D, Zoehrer B, Paulke-Korinek M, Gruber-Sedlmayr U, Pfurtscheller K, Strenger V, et al.
Eur J Pediatr
. 2014 Jan;
173(7):871-8.
PMID: 24419336
Unlabelled: The present study was conducted to evaluate the burden of pneumococcal meningitis in Austrian children between 2001 and 2008. Clinical outcome was retrospectively analyzed both on discharge and on...
3.
Kaltenbock A, Dubischar-Kastner K, Eder G, Jilg W, Klade C, Kollaritsch H, et al.
Vaccine
. 2009 Jun;
27(33):4483-9.
PMID: 19486955
In travellers often several pre-departure immunizations are indicated, thus data are needed about possible interactions between vaccines. This Phase 3 study investigated the immunogenicity and safety of IC51 (JE vaccine)...
4.
Rendi-Wagner P, Paulke-Korinek M, Kundi M, Burgmann H, Georgopoulos A, Vecsei A, et al.
Vaccine
. 2009 Apr;
27(30):3963-8.
PMID: 19393711
This study monitors the epidemiology of invasive pneumococcal diseases (IPD) in hospitalized children up to 60 months of age before (February 2001-October 2004) and after (November 2004-January 2007) the introduction...
5.
Weinke T, Liebold I, Burchard G, Fruhwein N, Grobusch M, Hatz C, et al.
Travel Med Infect Dis
. 2008 Nov;
6(6):362-7.
PMID: 18984481
Traveller's diarrhoea (TD) constitutes the most common disease relevant to travel medicine with ETEC as the leading causative pathogen. Cholera is the most serious, but very rare form of TD....
6.
Schuller E, Jilma B, Voicu V, Golor G, Kollaritsch H, Kaltenbock A, et al.
Vaccine
. 2008 Jul;
26(34):4382-6.
PMID: 18599165
Japanese encephalitis (JE) is the most common viral encephalitis in Asia. IC51 is a new Vero cell-derived, inactivated JE virus vaccine with non-inferior immunogenicity (after 2 months) compared to the...
7.
Tauber E, Kollaritsch H, von Sonnenburg F, Lademann M, Jilma B, Firbas C, et al.
J Infect Dis
. 2008 Jul;
198(4):493-9.
PMID: 18588481
Background: Japanese encephalitis (JE) is the most important mosquito-borne viral encephalitis and has a high case fatality rate. It is caused by Japanese encephalitis virus. Improved vaccines are urgently needed...
8.
Tauber E, Kollaritsch H, Korinek M, Rendi-Wagner P, Jilma B, Firbas C, et al.
Lancet
. 2007 Dec;
370(9602):1847-53.
PMID: 18061060
Background: Japanese encephalitis virus (JEV) is the leading cause of viral encephalitis in southeast Asia. Although no treatment is currently available, vaccination effectively prevents the disease. In a non-inferiority study,...
9.
Weinke T, Liebold I, Burchard G, Fruhwein N, Grobusch M, Hatz C, et al.
Dtsch Med Wochenschr
. 2006 Jul;
131(30):1660-4.
PMID: 16850383
No abstract available.
10.
Nothdurft H, Bialek R, Burchard G, Hatz C, Jelinek T, Kollaritsch H, et al.
Dtsch Med Wochenschr
. 2005 May;
130(22):1392-6.
PMID: 15915383
No abstract available.